You need to enable JavaScript to view this site.
Skip to Content
Rankings
See All Rankings
Fortune 500
Global 500
40 Under 40
Magazine
Newsletters
Podcasts
COVID-19
More
Video On Demand
Fortune Live Media
Fortune Connect
SEARCH
SEARCH
SIGN IN
coronavirus
221 pages
Newsletters
Brexit has saddled its champions with an impossible dilemma
By
David Meyer
March 5, 2021
Newsletters
As the markets bomb lower, this one sector continues to rally
By
Bernhard Warner
March 5, 2021
Newsletters
What happens when you don’t live near a pharmacy for a COVID vaccine?
By
Sy Mukherjee
March 4, 2021
Health
State-by-state map: Georgia and D.C. lag in COVID vaccine rollout
By
Erika Fry
and
Nicolas Rapp
March 4, 2021
Newsletters
Easy come, easy go
By
Alan Murray
and
David Meyer
March 4, 2021
Newsletters
The markets have an Achilles heel: twitchy bond yields
By
Bernhard Warner
March 4, 2021
Health
No pharmacy for miles: How rural Americans are getting overlooked in the COVID vaccine rollout
By
Sy Mukherjee
March 4, 2021
Health
Only one of the Big Four vaccine makers produced a COVID-19 winner. What happens next?
By
Kat Eschner
March 3, 2021
Newsletters
The impact of remote work
By
Alan Murray
and
David Meyer
March 3, 2021
Newsletters
Bitcoin and global stocks bounce back
By
Bernhard Warner
March 3, 2021
Finance
‘It is now time to open Texas 100%’: Lone Star State lifts statewide mask mandate
By
Lance Lambert
March 3, 2021
Health
Biden set to announce vaccine manufacturing partnership between Merck and Johnson & Johnson
By
Andrew Marquardt
March 2, 2021
Newsletters
The warning light is flashing on this closely watched Wall Street indicator
By
Bernhard Warner
March 2, 2021
Newsletters
Which U.S. company has the most tangible assets on its books?
By
Alan Murray
and
David Meyer
March 2, 2021
1 - 14
of
3,309
results
1
2
3
…
237
Next Page
1 - 14
of
3,309
results
1
2
3
…
237
Next Page